Bosh sahifa532523 • BOM
add
Biocon Ltd
Yopilish kursi
323,15 ₹
Kunlik diapazon
322,45 ₹ - 332,30 ₹
Yillik diapazon
231,35 ₹ - 395,65 ₹
Bozor kapitalizatsiyasi
396,60 mlrd INR
Oʻrtacha hajm
170,80 ming
Narx/foyda
27,55
Dividend daromadliligi
0,15%
Asosiy maydon
NSE
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(INR) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Daromad | 35,90 mlrd | 3,70% |
Joriy xarajat | 21,42 mlrd | 8,03% |
Sof foyda | -160,00 mln | -112,74% |
Sof foyda marjasi | -0,45 | -112,40% |
Har bir ulushga tushum | -0,19 | -115,53% |
EBITDA | 6,78 mlrd | -6,58% |
Amaldagi soliq stavkasi | 72,46% | — |
Balans
Jami aktivlari
Jami passivlari
(INR) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Naqd pul va qisqa investitsiyalar | 26,50 mlrd | -30,00% |
Jami aktivlari | 571,28 mlrd | 4,67% |
Jami passivlari | 304,08 mlrd | 0,36% |
Umumiy kapital | 267,20 mlrd | — |
Tarqatilgan aksiyalar | 1,23 mlrd | — |
Narxi/balansdagi bahosi | 1,89 | — |
Aktivlardan daromad | — | — |
Kapitaldan daromad | 1,56% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
(INR) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Sof foyda | -160,00 mln | -112,74% |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, India. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
Tashkil etilgan
1978
Bosh ofis
Sayt
Xodimlar soni
16 315